PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 5:34 AM ET

Sponsor Check › Person

DM
No photo found yet (own website and image search run after this page is viewed)

Dylan Morris

Named as an officer, director or promoter on SEC Form D filings · CA, NY, MA, TX · Feb 17, 2012 → Feb 8, 2024

10deals (issuers)
$314.5Mreported sold
127investors
20Form D filings
2012–2024years on file
Follow this personLook further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 3:06 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Dylan Morris is listed as a director on 20 SEC Form D filings by 10 issuers between Feb 2012 and Sep 2026. Largest by amount reported sold: Averna Therapeutics Inc. (Watertown, MA — other health care — 2024–2026; $85M reported sold to 13 investors), Superluminal Medicines, Inc. (Boston, MA — biotechnology — 2023–2026; $65.5M reported sold to 16 investors), Unlearn.ai, Inc. (San Francisco, CA — industry reported as "Other" — 2022–2024; $50M reported sold to 14 investors), Gameto, Inc. (Bee Cave, TX — biotechnology — 2022–2024; $44M reported sold to 26 investors), Switch Therapeutics Inc. (South San Francisco, CA — industry reported as "Other" — 2022; $23.3M reported sold to 15 investors) and 5 more (all listed below).

What this means That is a lot of deals — 10 separate companies raised money with this person listed as director, over about 14 years. Across those companies the filings report $314.5M sold in total.

Listed alongside CONY D'CRUZ (4 shared filings), Andrew Levin (3 shared filings), DIAMANTIS XYLAS (3 shared filings), Dina Radenkovic (3 shared filings), Henry Chen (3 shared filings) and 54 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Dylan. Each name links to their own page.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 3 bankruptcy cases matching the name listed in Key records below.

What this means 3 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.

We compared 20 public filings for Dylan Morris and found 6 differences, 1 worth asking the sponsor about: 4 Form Ds were filed more than 15 days after the first sale; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Dylan Morris has not run yet — it is joining a line of 18,627 names; searches run around the clock at the hosts' allowed rate. Searched so far: 29 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 3:06 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: AZ, CA, DE, TX, WA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Dylan Morris..

State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states are not covered.

3. Bankruptcies

3 cases: 1 open, 2 closed (disposition not in docket feed)

Dylan S Morris open
United States Bankruptcy Court, N.D. Indiana · No. 26-31168 · Filed Jul 27, 2026
Role of Dylan S Morris: Debtor · Outcome: Open — no termination date on the docket (bulk snapshot 2026-09-30) Docket on CourtListener ↗
same full name (a name found in 4 federal dockets); court in IN (not a filing state)
Dylan H Morris closed
United States Bankruptcy Court, N.D. Alabama · No. 22-00564 · Filed Mar 11, 2022 · Closed Jun 28, 2022
Role of Dylan H Morris: Debtor · Outcome: Case closed 2022-06-28 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 4 federal dockets); court in AL (not a filing state)
Dylan K Morris and Debra K Morris closed
United States Bankruptcy Court, S.D. Ohio · No. 1:00-bk-13273 · Filed Jun 16, 2000 · Closed Oct 5, 2000
Role of Dylan K Morris and Debra K Morris: Debtor · Outcome: Case closed 2000-10-05 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 4 federal dockets); court in OH (not a filing state)
What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 3:06 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

6 differences found between the filings for Dylan Morris — 1 worth asking about (compared 20 filings on Oct 24, 2026)

Worth asking · Jun 10, 2022 – Sep 3, 2026

4 Form Ds were filed more than 15 days after the first sale

Form D filed 178 days after the first sale — Superluminal Medicines, Inc. · Form D filed 89 days after the first sale — Gameto, Inc. · Form D filed 24 days after the first sale — Superluminal Medicines, Inc. · Form D filed 28 days after the first sale — Capacity Bio, Inc.

What this means Late notices are common and carry no penalty by themselves. A pattern of late paperwork is worth asking the sponsor about.

Form D · Aug 28, 2023 ↗Superluminal Medicines, Inc. — PartnerFacts page ↗Form D · Sep 7, 2022 ↗Gameto, Inc. — PartnerFacts page ↗
Sources
Note · Oct 5, 2022 – Nov 17, 2022

Offering amount changed between filings — Switch Therapeutics Inc.

The Oct 5, 2022 filing says $34,999,989 offered; the Nov 17, 2022 Form D/A says $35,984,988.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Form D (earlier) · Oct 5, 2022 ↗Form D/A (later) · Nov 17, 2022 ↗Switch Therapeutics Inc. — PartnerFacts page ↗
Sources
Note · Jan 11, 2022 – Sep 7, 2022

Offering amount changed between filings — Gameto, Inc.

The Jan 11, 2022 filing says $19,999,947 offered; the Sep 7, 2022 Form D/A says $26,999,944.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Form D (earlier) · Jan 11, 2022 ↗Form D/A (later) · Sep 7, 2022 ↗Gameto, Inc. — PartnerFacts page ↗
Sources
Note · Jun 28, 2019 – Apr 2, 2025

8 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — ImmuneBridge Inc. (latest filing Apr 2, 2025) · No amendment in the last 12 months on an offering that may still be open — Superluminal Medicines, Inc. (latest filing Sep 4, 2024) · No amendment in the last 12 months on an offering that may still be open — Capacity Bio, Inc. (latest filing Jan 18, 2023) · No amendment in the last 12 months on an offering that may still be open — ImmuneBridge Inc. (latest filing Jan 10, 2023) · No amendment in the last 12 months on an offering that may still be open — Switch Therapeutics Inc. (latest filing Nov 17, 2022) · and 3 more

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Form D · Apr 2, 2025 ↗ImmuneBridge Inc. — PartnerFacts page ↗Form D · Sep 4, 2024 ↗Superluminal Medicines, Inc. — PartnerFacts page ↗
Sources
Note · Sep 7, 2022 – Aug 26, 2025

4 address changes between filings

Address moved from Waltham, MA to Boston, MA — Superluminal Medicines, Inc. · Address moved from New York, NY to Watertown, MA — Averna Therapeutics Inc. · Address moved from Boston, MA to Waltham, MA — Superluminal Medicines, Inc. · Address moved from New York, NY to Austin, TX — Gameto, Inc.

What this means Businesses move. If you were told one city and the forms say another, ask which is current.

Form D · Sep 4, 2024 ↗Form D · Aug 26, 2025 ↗Superluminal Medicines, Inc. — PartnerFacts page ↗Form D · Apr 17, 2024 ↗
Sources
Note · Feb 17, 2012 – Sep 3, 2026

Dylan Morris is listed with 4 different address states: CA, NY, MA, TX

CA on 8 filings (Feb 17, 2012 to Feb 8, 2024); NY on 5 filings (Aug 30, 2022 to Apr 2, 2025); MA on 6 filings (Aug 28, 2023 to Sep 3, 2026); TX on 1 filing (May 29, 2024).

What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.

Form D · Feb 17, 2012 ↗Form D · Aug 30, 2022 ↗Form D · Aug 28, 2023 ↗Form D · May 29, 2024 ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

None reported on 17 offerings — no sales commissions, finder's fees or proceeds to insiders

Per-offering detail
Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Sep 3, 2026 D
Superluminal Medicines, Inc.
File 021-596351
$0$0$0None listed on this filingEDGAR ↗
Mar 20, 2026 D/A
Averna Therapeutics Inc.
File 021-510828
$0$0$0None listed on this filingEDGAR ↗
Aug 26, 2025 D
Superluminal Medicines, Inc.
File 021-555850
$0$0$0None listed on this filingEDGAR ↗
Apr 2, 2025 D
ImmuneBridge Inc.
File 021-542721
$0$0$0None listed on this filingEDGAR ↗
Sep 4, 2024 D
Superluminal Medicines, Inc.
File 021-523131
$0$0$0None listed on this filingEDGAR ↗
May 29, 2024 D
Gameto, Inc.
File 021-514495
$0$0$0None listed on this filingEDGAR ↗
Feb 8, 2024 D
Unlearn.ai, Inc.
File 021-504739
$0$0$0None listed on this filingEDGAR ↗
Aug 28, 2023 D
Superluminal Medicines, Inc.
File 021-490789
$0$0$0None listed on this filingEDGAR ↗
Jan 18, 2023 D
Capacity Bio, Inc.
File 021-470977
$0$0$0None listed on this filingEDGAR ↗
Jan 10, 2023 D
ImmuneBridge Inc.
File 021-470133
$0$0$0None listed on this filingEDGAR ↗
Nov 17, 2022 D/A
Switch Therapeutics Inc.
File 021-460733
$0$0$0None listed on this filingEDGAR ↗
Sep 7, 2022 D/A
Gameto, Inc.
File 021-428844
$0$0$0None listed on this filingEDGAR ↗
Sep 7, 2022 D
Gameto, Inc.
File 021-458228
$0$0$0None listed on this filingEDGAR ↗
Aug 30, 2022 D
Profluent Bio Inc.
File 021-457461
$0$0$0None listed on this filingEDGAR ↗
Apr 19, 2022 D
Unlearn.ai, Inc.
File 021-442493
$0$0$0None listed on this filingEDGAR ↗
Jul 10, 2019 D
Deciduous Therapeutics, Inc.
File 021-343931
$0$0$0None listed on this filingEDGAR ↗
Feb 17, 2012 D
Integrated Plasmonics Corp
File 021-173639
$0$0$0None listed on this filingEDGAR ↗

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 10

Every issuer that named Dylan Morris on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

SM
Biotechnology

Superluminal Medicines, Inc.

Boston, MA · Aug 28, 2023 → Sep 3, 2026 · 4 filings
  • Sep 3, 2026 · D · $65,480,796 sold of $65,480,796 · 16 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 26, 2025 · D · $5,000,000 sold of $5,000,000 · 1 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 4, 2024 · D · $20,041,660 sold of $119,999,984 · 12 investors · min. No minimum reported · role: Director EDGAR ↗
  • Aug 28, 2023 · D · $25,679,107 sold of $25,679,107 · 7 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $65.5M from 16 investors (100% of the $65.5M target) as of the latest filing. Dylan is listed as director on 4 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

AT
Other Health Care

Averna Therapeutics Inc.

Watertown, MA · Apr 17, 2024 → Mar 20, 2026 · 3 filings
  • Mar 20, 2026 · D/A · $84,999,995 sold of $85,000,000 · 13 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 21, 2025 · D/A · $43,769,227 sold of $85,000,000 · 13 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 17, 2024 · D · $38,769,227 sold of $85,000,000 · 13 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $85M from 13 investors (100% of the $85M target) as of the latest filing. Dylan is listed as director on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other Health Care / 506(b) (4,189 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

I
Biotechnology

ImmuneBridge Inc.

San Francisco, CA · Jan 10, 2023 → Apr 2, 2025 · 2 filings
  • Apr 2, 2025 · D · $5,632,000 sold of $7,132,000 · 6 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jan 10, 2023 · D · $10,150,000 sold of $14,150,000 · 15 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $10.2M from 15 investors (100% of the $7.13M target) as of the latest filing. Dylan is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

G
Biotechnology

Gameto, Inc.

Bee Cave, TX · Sep 7, 2022 → May 29, 2024 · 3 filings
  • May 29, 2024 · D · $42,999,962 sold of $42,999,962 · 26 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 7, 2022 · D · $9,561,635 sold of $10,000,000 · 10 investors · min. No minimum reported · role: Director EDGAR ↗
  • Sep 7, 2022 · D/A · $26,999,944 sold of $26,999,944 · 20 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $44M from 26 investors (100% of the $43M target) as of the latest filing. Dylan is listed as director on 3 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

UA
Other

Unlearn.ai, Inc.

San Francisco, CA · Apr 19, 2022 → Feb 8, 2024 · 2 filings
  • Feb 8, 2024 · D · $49,999,956 sold of $49,999,956 · 9 investors · min. No minimum reported · role: Director EDGAR ↗
  • Apr 19, 2022 · D · $49,999,991 sold of $49,999,991 · 14 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $50M from 14 investors (100% of the $50M target) as of the latest filing. Dylan is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other / 506(b) (18,678 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

CB
Pharmaceuticals

Capacity Bio, Inc.

Palo Alto, CA · Jan 18, 2023
  • Jan 18, 2023 · D · $19,210,937 sold of $35,329,982 · 13 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $19.2M from 13 investors (54% of the $35.3M target) as of the latest filing. Dylan is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Pharmaceuticals / 506(b) (800 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

ST
Other

Switch Therapeutics Inc.

South San Francisco, CA · Oct 5, 2022 → Nov 17, 2022 · 2 filings
  • Nov 17, 2022 · D/A · $23,270,993 sold of $35,984,988 · 15 investors · min. No minimum reported · role: Director EDGAR ↗
  • Oct 5, 2022 · D · $19,870,995 sold of $34,999,989 · 13 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $23.3M from 15 investors (65% of the $36M target) as of the latest filing. Dylan is listed as director on 2 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Other / 506(b) (18,678 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

PB
Biotechnology

Profluent Bio Inc.

San Francisco, CA · Aug 30, 2022
  • Aug 30, 2022 · D · $8,000,000 sold of $9,000,000 · 2 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $8M from 2 investors (89% of the $9M target) as of the latest filing. Dylan is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

DT
Biotechnology

Deciduous Therapeutics, Inc.

San Francisco, CA · Jul 10, 2019
  • Jul 10, 2019 · D · $5,845,832 sold of $6,500,000 · 10 investors · min. $10,000 · role: Director EDGAR ↗

Raised $5.85M from 10 investors (90% of the $6.5M target) as of the latest filing. Dylan is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

IP
Other Technology

Integrated Plasmonics Corp

Palo Alto, CA · Feb 17, 2012
  • Feb 17, 2012 · D · $3,538,027 sold of $3,538,027 · 3 investors · min. $25,000 · role: Director EDGAR ↗

Raised $3.54M from 3 investors (100% of the $3.54M target) as of the latest filing. Dylan is listed as director.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

People around Dylan 40

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET. Showing the 40 with the most shared filings.

CC
No photo found yet (own website and image search run after this page is viewed)
Person

CONY D'CRUZ

Executive Officer, Director, Promoter · 4 shared filings (1 issuer)

Listed on the same filings as Dylan Morris. Their page shows their other deals.

AL
No photo found yet (own website and image search run after this page is viewed)
Person

Andrew Levin

Director · 3 shared filings (1 issuer) · also on 20 other issuers

Andrew Levin is on 21 issuers in total — a repeat sponsor. Their page lists every one.

SS
No photo found yet (own website and image search run after this page is viewed)
Person

Stephen Squinto

Director · 3 shared filings (1 issuer) · also on 15 other issuers

Stephen Squinto is on 16 issuers in total — a repeat sponsor. Their page lists every one.

HC
No photo found yet (own website and image search run after this page is viewed)
Person

Henry Chen

Director · 3 shared filings (1 issuer) · also on 8 other issuers

Henry Chen is on 9 issuers in total — a repeat sponsor. Their page lists every one.

MS
No photo found yet (own website and image search run after this page is viewed)
Person

Maryanna Saenko

Director · 3 shared filings (1 issuer) · also on 18 other issuers

Maryanna Saenko is on 19 issuers in total — a repeat sponsor. Their page lists every one.

DR
No photo found yet (own website and image search run after this page is viewed)
Person

Dina Radenkovic

Executive Officer, Director · 3 shared filings (1 issuer)

Listed on the same filings as Dylan Morris. Their page shows their other deals.

MV
No photo found yet (own website and image search run after this page is viewed)
Person

Martin Varsavsky

Director, Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Dylan Morris. Their page shows their other deals.

DX
No photo found yet (own website and image search run after this page is viewed)
Person

DIAMANTIS XYLAS

Director · 3 shared filings (1 issuer)

Listed on the same filings as Dylan Morris. Their page shows their other deals.

RA
No photo found yet (own website and image search run after this page is viewed)
Person

Roy Amariglio

Director, Executive Officer · 3 shared filings (1 issuer)

Listed on the same filings as Dylan Morris. Their page shows their other deals.

FG
No photo found yet (own website and image search run after this page is viewed)
Person

Francisco Gimenez

Director · 2 shared filings (1 issuer) · also on 6 other issuers

Francisco Gimenez is on 7 issuers in total — a repeat sponsor. Their page lists every one.

KZ
No photo found yet (own website and image search run after this page is viewed)
Person

Kevin Zhang

Director · 2 shared filings (1 issuer) · also on 8 other issuers

Kevin Zhang is on 9 issuers in total — a repeat sponsor. Their page lists every one.

AS
No photo found yet (own website and image search run after this page is viewed)
Person

Aaron Smith

Executive Officer, Director · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Dylan Morris. Their page shows their other deals.

CF
No photo found yet (own website and image search run after this page is viewed)
Person

Charles Fisher

Executive Officer, Director · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Dylan Morris. Their page shows their other deals.

AT
No photo found yet (own website and image search run after this page is viewed)
Person

Ann Taylor

Director · 2 shared filings (1 issuer)

Listed on the same filings as Dylan Morris. Their page shows their other deals.

AL
No photo found yet (own website and image search run after this page is viewed)
Person

Alicia Irurzun-Lafitte

Director · 2 shared filings (1 issuer)

Listed on the same filings as Dylan Morris. Their page shows their other deals.

SH
No photo found yet (own website and image search run after this page is viewed)
Person

Si-Ping Han

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Dylan Morris. Their page shows their other deals.

DD
No photo found yet (own website and image search run after this page is viewed)
Person

Deepshikha Datta

Executive Officer, Director · 2 shared filings (1 issuer)

Listed on the same filings as Dylan Morris. Their page shows their other deals.

AJ
No photo found yet (own website and image search run after this page is viewed)
Person

Alicia Jackson

Director · 2 shared filings (1 issuer)

Listed on the same filings as Dylan Morris. Their page shows their other deals.

CR
No photo found yet (own website and image search run after this page is viewed)
Person

CATHERINE RIESEN

Executive Officer · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Dylan Morris. Their page shows their other deals.

TD
No photo found yet (own website and image search run after this page is viewed)
Person

Tal Zaks, M.D., Ph.D.

Director, Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Dylan Morris. Their page shows their other deals.

AN
No photo found yet (own website and image search run after this page is viewed)
Person

Anat Nursella

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Dylan Morris. Their page shows their other deals.

AN
No photo found yet (own website and image search run after this page is viewed)
Person

Aaron Nelson

Director · 2 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Dylan Morris. Their page shows their other deals.

JH
No photo found yet (own website and image search run after this page is viewed)
Person

John Hamer

Director · 1 shared filing (1 issuer) · also on 10 other issuers

John Hamer is on 11 issuers in total — a repeat sponsor. Their page lists every one.

MH
No photo found yet (own website and image search run after this page is viewed)
Person

Mamoon Hamid

Director · 1 shared filing (1 issuer) · also on 35 other issuers

Mamoon Hamid is on 36 issuers in total — a repeat sponsor. Their page lists every one.

CP
No photo found yet (own website and image search run after this page is viewed)
Person

Chamath Palihapitiya

Director · 1 shared filing (1 issuer) · also on 22 other issuers

Chamath Palihapitiya is on 23 issuers in total — a repeat sponsor. Their page lists every one.

GB
No photo found yet (own website and image search run after this page is viewed)
Person

Gregory A. Bonfiglio

Director · 1 shared filing (1 issuer) · also on 1 other issuer

Listed on the same filings as Dylan Morris. Their page shows their other deals.

ES
No photo found yet (own website and image search run after this page is viewed)
Person

Eric Shiozaki

Director · 1 shared filing (1 issuer) · also on 2 other issuers

Listed on the same filings as Dylan Morris. Their page shows their other deals.

TI
No photo found yet (own website and image search run after this page is viewed)
Person

TARO INABA

Director · 1 shared filing (1 issuer) · also on 5 other issuers

TARO INABA is on 6 issuers in total — a repeat sponsor. Their page lists every one.

AW
No photo found yet (own website and image search run after this page is viewed)
Person

Amy Wang

Executive Officer, Director · 1 shared filing (1 issuer) · also on 4 other issuers

Amy Wang is on 5 issuers in total — a repeat sponsor. Their page lists every one.

MS
No photo found yet (own website and image search run after this page is viewed)
Person

Michal Silverberg

Director · 1 shared filing (1 issuer) · also on 2 other issuers

Listed on the same filings as Dylan Morris. Their page shows their other deals.

RM
No photo found yet (own website and image search run after this page is viewed)
Person

Robin Mansukhani

Executive Officer, Director · 1 shared filing (1 issuer)

Listed on the same filings as Dylan Morris. Their page shows their other deals.

AB
No photo found yet (own website and image search run after this page is viewed)
Person

Anil Bhushan

Director · 1 shared filing (1 issuer)

Listed on the same filings as Dylan Morris. Their page shows their other deals.

JW
No photo found yet (own website and image search run after this page is viewed)
Person

Jonathan Ryan Walsh

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Dylan Morris. Their page shows their other deals.

NS
No photo found yet (own website and image search run after this page is viewed)
Person

Nandita Shangari

Director · 1 shared filing (1 issuer) · also on 4 other issuers

Nandita Shangari is on 5 issuers in total — a repeat sponsor. Their page lists every one.

OD
No photo found yet (own website and image search run after this page is viewed)
Person

Omri Amirav-Drory

Director · 1 shared filing (1 issuer) · also on 6 other issuers

Omri Amirav-Drory is on 7 issuers in total — a repeat sponsor. Their page lists every one.

AM
No photo found yet (own website and image search run after this page is viewed)
Person

Ali Madani

Executive Officer, Director · 1 shared filing (1 issuer)

Listed on the same filings as Dylan Morris. Their page shows their other deals.

CG
No photo found yet (own website and image search run after this page is viewed)
Person

Cristina Ghenoiu

Director · 1 shared filing (1 issuer)

Listed on the same filings as Dylan Morris. Their page shows their other deals.

CZ
No photo found yet (own website and image search run after this page is viewed)
Person

Cheryl Zimberlin

Director · 1 shared filing (1 issuer)

Listed on the same filings as Dylan Morris. Their page shows their other deals.

PP
No photo found yet (own website and image search run after this page is viewed)
Person

Peretz Partensky

Executive Officer, Director · 1 shared filing (1 issuer)

Listed on the same filings as Dylan Morris. Their page shows their other deals.

MW
No photo found yet (own website and image search run after this page is viewed)
Person

Mary Kim Warren

Director · 1 shared filing (1 issuer)

Listed on the same filings as Dylan Morris. Their page shows their other deals.

The team behind the deals

Same business address

49 other issuers file from the same address

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Adviser registration (Form ADV)

None of the 10 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Dylan Morris by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 10 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Dylan Morris is listed on: none on file. No website or social profile named in Unlearn.ai, Inc.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #107,533 of 374,652 in line (25 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (San Francisco, CA). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Social and web

LinkedIn people search ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗California — find the county court ↗Los Angeles Superior Court case search ↗New York WebCivil Supreme ↗Massachusetts MassCourts ↗Texas re:SearchTX court records ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

California Secretary of State business search ↗New York Secretary of State business search ↗Massachusetts Secretary of State business search ↗Texas Secretary of State business search ↗OpenCorporates ↗

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Dylan Morris appears on a new Form D, or when a court case or SEC action is matched to them. See plans →